Triple-negative breast cancer (TNBC) is defined by little or lack of expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER-2)1. This evidence concerns the gene ESR1 and triple-negative breast carcinoma.